<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK447257" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK447257/" /><meta name="ncbi_pagename" content="TRIO-Related Intellectual Disability - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>TRIO-Related Intellectual Disability - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="TRIO-Related Intellectual Disability" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2017/08/10" /><meta name="citation_author" content="Konstantinos Varvagiannis" /><meta name="citation_author" content="Lisenka ELM Vissers" /><meta name="citation_author" content="Diana Baralle" /><meta name="citation_author" content="Bert BA de Vries" /><meta name="citation_pmid" content="28796471" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK447257/" /><meta name="citation_keywords" content="Triple functional domain protein" /><meta name="citation_keywords" content="TRIO" /><meta name="citation_keywords" content="TRIO-Related Intellectual Disability" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="TRIO-Related Intellectual Disability" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Konstantinos Varvagiannis" /><meta name="DC.Contributor" content="Lisenka ELM Vissers" /><meta name="DC.Contributor" content="Diana Baralle" /><meta name="DC.Contributor" content="Bert BA de Vries" /><meta name="DC.Date" content="2017/08/10" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK447257/" /><meta name="description" content="TRIO-related intellectual disability (ID) is characterized by delay in acquisition of motor and language skills, mild to borderline intellectual disability, and neurobehavioral problems (including autistic traits or autism spectrum disorder, attention-deficit/hyperactivity disorder, and/or aggression). Neonatal or infantile feeding difficulties including poor suck, impaired bottle feeding, and failure to thrive are common and are often the presenting finding. Other findings can include microcephaly, variable hand and dental abnormalities, and suggestive facial features. Only ten of the 20 individuals with a TRIO pathogenic variant reported to date had sufficient information to make preliminary generalizations about clinical manifestations; it is anticipated that the phenotype of this newly described disorder will continue to evolve." /><meta name="og:title" content="TRIO-Related Intellectual Disability" /><meta name="og:type" content="book" /><meta name="og:description" content="TRIO-related intellectual disability (ID) is characterized by delay in acquisition of motor and language skills, mild to borderline intellectual disability, and neurobehavioral problems (including autistic traits or autism spectrum disorder, attention-deficit/hyperactivity disorder, and/or aggression). Neonatal or infantile feeding difficulties including poor suck, impaired bottle feeding, and failure to thrive are common and are often the presenting finding. Other findings can include microcephaly, variable hand and dental abnormalities, and suggestive facial features. Only ten of the 20 individuals with a TRIO pathogenic variant reported to date had sufficient information to make preliminary generalizations about clinical manifestations; it is anticipated that the phenotype of this newly described disorder will continue to evolve." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK447257/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/trio-id/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK447257/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8910E7DFC8726100000000045701F7.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK447257_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK447257_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/aec/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/cmt2c/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK447257_"><span class="title" itemprop="name"><i>TRIO</i>-Related Intellectual Disability</span></h1><p class="contrib-group"><span itemprop="author">Konstantinos Varvagiannis</span>, MD, <span itemprop="author">Lisenka ELM Vissers</span>, PhD, <span itemprop="author">Diana Baralle</span>, BSc, MBBS, MD, FRCP, and <span itemprop="author">Bert BA de Vries</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK447257_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK447257_ai__"><div class="contrib half_rhythm"><span itemprop="author">Konstantinos Varvagiannis</span>, MD<div class="affiliation small">Department of Genetics<br />Institute of Child Health<br />Athens, Greece<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="rg.tenhtrof.hta@vravsnk" class="oemail">rg.tenhtrof.hta@vravsnk</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Lisenka ELM Vissers</span>, PhD<div class="affiliation small">Department of Human Genetics<br />Radboud University Medical Center<br />Nijmegen, The Netherlands<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ln.cmuduobdar@sressiv.aknesil" class="oemail">ln.cmuduobdar@sressiv.aknesil</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Diana Baralle</span>, BSc, MBBS, MD, FRCP<div class="affiliation small">University of Southampton<br />Southampton General Hospital<br />Southampton, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.notos@ellarab.d" class="oemail">ku.ca.notos@ellarab.d</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Bert BA de Vries</span>, MD, PhD<div class="affiliation small">Department of Human Genetics<br />Radboud University Medical Center<br />Nijmegen, The Netherlands<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ln.cmuduobdar@seirved.treb" class="oemail">ln.cmuduobdar@seirved.treb</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">August 10, 2017</span>.</p><p><em>Estimated reading time: 18 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="trio-id.Summary" itemprop="description"><h2 id="_trio-id_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>TRIO</i>-related intellectual disability (ID) is characterized by delay in acquisition of motor and language skills, mild to borderline intellectual disability, and neurobehavioral problems (including autistic traits or autism spectrum disorder, attention-deficit/hyperactivity disorder, and/or aggression). Neonatal or infantile feeding difficulties including poor suck, impaired bottle feeding, and failure to thrive are common and are often the presenting finding. Other findings can include microcephaly, variable hand and dental abnormalities, and suggestive facial features. Only ten of the 20 individuals with a <i>TRIO</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> reported to date had sufficient information to make preliminary generalizations about clinical manifestations; it is anticipated that the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of this newly described disorder will continue to evolve.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of <i>TRIO</i>-related ID is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>TRIO</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Treatment is symptomatic and includes routine management of developmental delays / ID, social and behavior problems, feeding difficulty, and dental abnormalities.</p><p><i>Surveillance:</i> Regular dietary evaluation in infancy to ensure optimal nutritional status; monitoring of developmental progress and educational needs; behavioral assessment for attention, aggression, and/or social communication difficulties; regular dental evaluations.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>TRIO</i>-related ID is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. The majority of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>; between 20% and 40% have inherited the <i>TRIO</i> pathogenic variant from a similarly affected parent. Each child of an individual with <i>TRIO</i>-related ID has a 50% chance of inheriting the <i>TRIO</i> pathogenic variant. Once the <i>TRIO</i> pathogenic variant has been identified in an affected family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="trio-id.Diagnosis"><h2 id="_trio-id_Diagnosis_">Diagnosis</h2><p>No formal clinical diagnostic criteria for <i>TRIO</i>-related intellectual disability (ID) exist.</p><div id="trio-id.Suggestive_Findings"><h3>Suggestive Findings</h3><p><i>TRIO</i>-related ID <b>should be considered</b> in individuals with the following clinical findings:</p><ul><li class="half_rhythm"><div>Delayed speech and fine/gross motor development AND/OR mild (IQ 50-70) to borderline (IQ 70-85) ID; AND</div></li><li class="half_rhythm"><div>One or more of the following:</div><ul><li class="half_rhythm"><div>Microcephaly; occipital-frontal circumference &#x0003c;2 SD</div></li><li class="half_rhythm"><div>Minor hand anomalies including short tapering fingers / brachydactyly, broad proximal interphalangeal joints, and clinodactyly of the fifth finger</div></li><li class="half_rhythm"><div>Dental anomalies including dental crowding and delayed or failed tooth eruption</div></li><li class="half_rhythm"><div>Facial features including facial asymmetry and/or micrognathia</div></li></ul></li></ul><p>Other, less specific features:</p><ul><li class="half_rhythm"><div>Neonatal feeding problems that may persist into infancy</div></li><li class="half_rhythm"><div>Behavioral problems including autistic traits or autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), and/or aggression</div></li><li class="half_rhythm"><div>Spinal deformities including scoliosis and/or kyphosis</div></li></ul></div><div id="trio-id.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of <i>TRIO</i>-related ID <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>TRIO</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK447257/table/trio-id.T.molecular_genetic_testing_used/?report=objectonly" target="object" rid-figpopup="figtrioidTmoleculargenetictestingused" rid-ob="figobtrioidTmoleculargenetictestingused">Table 1</a>).</p><p>Molecular genetic testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>) and <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> or single-gene testing).</p><p>Gene-targeted testing requires the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. As phenotypes of inherited intellectual disability often overlap, most individuals with <i>TRIO</i>-related ID are diagnosed by the following <a href="#trio-id.Recommended_Testing">recommended testing</a> or <a href="#trio-id.Testing_to_Consider">testing to consider</a>.</p><div id="trio-id.Recommended_Testing"><h4>Recommended Testing</h4><p><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>TRIO</i> and other genes of interest (see <a href="#trio-id.Differential_Diagnosis">Differential Diagnosis</a>). Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Of note, given the rarity of <i>TRIO</i>-related ID, many panels for intellectual disability may not include this gene.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p></div><div id="trio-id.Testing_to_Consider"><h4>Testing to Consider</h4><p><b>Comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> (when clinically available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> and genome sequencing. For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><p>Note: Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing (<a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>TRIO</i>, followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>) is rarely useful and typically NOT recommended.</p><div id="trio-id.T.molecular_genetic_testing_used" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>TRIO</i>-Related Intellectual Disability</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK447257/table/trio-id.T.molecular_genetic_testing_used/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__trio-id.T.molecular_genetic_testing_used_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_trio-id.T.molecular_genetic_testing_used_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_trio-id.T.molecular_genetic_testing_used_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_trio-id.T.molecular_genetic_testing_used_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic<br />Variant&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_trio-id.T.molecular_genetic_testing_used_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>TRIO</i></td><td headers="hd_h_trio-id.T.molecular_genetic_testing_used_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_trio-id.T.molecular_genetic_testing_used_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">7/8&#x000a0;<sup>4</sup> or 16/18&#x000a0;<sup>5</sup></td></tr><tr><td headers="hd_h_trio-id.T.molecular_genetic_testing_used_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>6</sup></td><td headers="hd_h_trio-id.T.molecular_genetic_testing_used_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1/8&#x000a0;<sup>7</sup> or 2/18&#x000a0;<sup>5</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="trio-id.TF.1.1"><p class="no_margin">See <a href="/books/NBK447257/#trio-id.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="trio-id.TF.1.2"><p class="no_margin">See <a href="#trio-id.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="trio-id.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="trio-id.TF.1.4"><p class="no_margin"><a class="bk_pop" href="#trio-id.REF.ba.2016.892">Ba et al [2016]</a>, <a class="bk_pop" href="#trio-id.REF.pengelly.2016.735">Pengelly et al [2016]</a></p></div></dd><dt>5. </dt><dd><div id="trio-id.TF.1.5"><p class="no_margin">Proportions when including additional individuals in cohorts with ID or ASD found to have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>TRIO</i> variant (presumed to be pathogenic due to their <i>de novo</i> occurrence and the relevant &#x02212; though not sufficiently evaluated &#x02212; clinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>) [<a class="bk_pop" href="#trio-id.REF.de_ligt.2012.1921">de Ligt et al 2012</a>, <a class="bk_pop" href="#trio-id.REF.oroak.2012.246">O'Roak et al 2012</a>, <a class="bk_pop" href="#trio-id.REF.sanders.2012.237">Sanders et al 2012</a>, <a class="bk_pop" href="#trio-id.REF.allen.2013.217">Allen et al 2013</a>, <a class="bk_pop" href="#trio-id.REF.de_rubeis.2014.209">De Rubeis et al 2014</a>, <a class="bk_pop" href="#trio-id.REF.iossifov.2014.216">Iossifov et al 2014</a>, <a class="bk_pop" href="#trio-id.REF.fitzgerald.2015.223">Fitzgerald et al 2015</a>]. An additional individual with a <i>de novo</i> intragenic <i>TRIO</i> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> was reported by the Deciphering Developmental Disorders Study [<a class="bk_pop" href="#trio-id.REF.fitzgerald.2015.223">Fitzgerald et al 2015</a>]. Note that individual #1 from <a class="bk_pop" href="#trio-id.REF.pengelly.2016.735">Pengelly et al [2016]</a> was also part of the Deciphering Developmental Disorders Study [<a class="bk_pop" href="#trio-id.REF.fitzgerald.2015.223">Fitzgerald et al 2015</a>].</p></div></dd><dt>6. </dt><dd><div id="trio-id.TF.1.6"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>7. </dt><dd><div id="trio-id.TF.1.7"><p class="no_margin"><a class="bk_pop" href="#trio-id.REF.ba.2016.892">Ba et al [2016]</a></p></div></dd></dl></div></div></div></div></div></div><div id="trio-id.Clinical_Characteristics"><h2 id="_trio-id_Clinical_Characteristics_">Clinical Characteristics</h2><div id="trio-id.Clinical_Description"><h3>Clinical Description</h3><p>To date, <i>TRIO</i>-related intellectual disability (ID) has been diagnosed in 20 individuals with a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>TRIO</i> variant identified in several cohorts with ID or autism spectrum disorder (ASD) [<a class="bk_pop" href="#trio-id.REF.de_ligt.2012.1921">de Ligt et al 2012</a>, <a class="bk_pop" href="#trio-id.REF.oroak.2012.246">O'Roak et al 2012</a>, <a class="bk_pop" href="#trio-id.REF.sanders.2012.237">Sanders et al 2012</a>, <a class="bk_pop" href="#trio-id.REF.allen.2013.217">Allen et al 2013</a>, <a class="bk_pop" href="#trio-id.REF.de_rubeis.2014.209">De Rubeis et al 2014</a>, <a class="bk_pop" href="#trio-id.REF.iossifov.2014.216">Iossifov et al 2014</a>, <a class="bk_pop" href="#trio-id.REF.fitzgerald.2015.223">Fitzgerald et al 2015</a>, <a class="bk_pop" href="#trio-id.REF.ba.2016.892">Ba et al 2016</a>, <a class="bk_pop" href="#trio-id.REF.pengelly.2016.735">Pengelly et al 2016</a>]. While the occurrence of a <i>TRIO</i>
<i>de novo</i> variant in an individual with ID/ASD would suggest pathogenicity, it is important to consider that because the phenotypic description of <i>TRIO</i>-related ID is incomplete to date, <i>de novo</i> occurrence alone is not sufficient to conclude that a variant is pathogenic [<a class="bk_pop" href="#trio-id.REF.richards.2015.405">Richards et al 2015</a>].</p><p>In ten of these 20 individuals (including the oldest, age 36 years) clinical information was sufficient to make preliminary generalizations about the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Characteristic findings are developmental delay, mild to borderline ID, and neurobehavioral problems as well as microcephaly, variable hand and dental abnormalities, and suggestive facial features. Nonetheless, a subset of these ten individuals for whom detailed phenotypic information is available do not have obvious clinical findings; thus, <i>TRIO</i>-related ID cannot consistently be identified (or even suspected) by clinical findings alone.</p><p><b>Developmental delay and intellectual disability.</b> All ten individuals had delay in attainment of both motor and speech milestones.</p><p>Nine of the ten individuals are verbal; in the most severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, first words emerged between ages three and five years. The one nonverbal child relied on alternative forms of communication at age nine years.</p><p>Four of the ten individuals had motor delay: sitting unsupported between age nine and 11 months, and walking unaided between age 17 months and four to five years [<a class="bk_pop" href="#trio-id.REF.pengelly.2016.735">Pengelly et al 2016</a>].</p><p>Eight of the ten clinically well-characterized individuals have mild ID; the other two appear to be functioning at the borderline/normal range of intellectual ability. Individuals in the latter group have experienced delays in language attainment as well as learning difficulties necessitating a specialized school environment. Of note, some individuals have been ascertained only following investigation of a more severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member.</p><p>A few older individuals with <i>TRIO</i>-related ID had significant/severe speech delay including the following:</p><ul><li class="half_rhythm"><div>Individual 1 [<a class="bk_pop" href="#trio-id.REF.ba.2016.892">Ba et al 2016</a>]. Able to speak five or six words at age seven years</div></li><li class="half_rhythm"><div>Individual 5 [<a class="bk_pop" href="#trio-id.REF.pengelly.2016.735">Pengelly et al 2016</a>]. First words spoken at age four or five years</div></li><li class="half_rhythm"><div>Individual 6 [<a class="bk_pop" href="#trio-id.REF.pengelly.2016.735">Pengelly et al 2016</a>]. Nonverbal at age nine years</div></li></ul><p><b>Behavioral <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</b> Behavioral problems reported in seven of ten of the individuals for whom sufficient clinical information exists include ASD, ADHD, stereotypies, obsessive-compulsive behavior, aggressiveness, self-mutilation, and disrupted sleep.</p><p>Of note, no information on the specific behavioral <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is available for the individuals with <i>TRIO</i>-related ID who were reported in the context of large ASD cohorts [<a class="bk_pop" href="#trio-id.REF.oroak.2012.246">O'Roak et al 2012</a>, <a class="bk_pop" href="#trio-id.REF.de_rubeis.2014.209">De Rubeis et al 2014</a>, <a class="bk_pop" href="#trio-id.REF.iossifov.2014.216">Iossifov et al 2014</a>].</p><p><b>Head size as determined by occipital-frontal circumference (OFC).</b> Microcephaly (&#x0003c;-2 SD) has been observed in seven of ten individuals, five of whom had an OFC 5 SD below the age-appropriate mean, indicating that significant microcephaly may be part of the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>A few <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have had head measurements within the normal range [<a class="bk_pop" href="#trio-id.REF.ba.2016.892">Ba et al 2016</a>] or even in the high percentiles [<a class="bk_pop" href="#trio-id.REF.pengelly.2016.735">Pengelly et al 2016</a>]. While data are lacking regarding the onset of microcephaly, postnatal onset was reported in one individual [<a class="bk_pop" href="#trio-id.REF.fitzgerald.2015.223">Fitzgerald et al 2015</a>].</p><p><b>Minor hand anomalies.</b> Short tapering fingers with broad proximal interphalangeal joints have been noted in the majority of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Other, rarer features may include fifth-finger clinodactyly or appearance of a short palm.</p><p><b>Dental anomalies</b> are dental crowding (4/10 individuals) and delayed or failed tooth eruption (2 additional individuals).</p><p><b>Facial gestalt.</b> There appears to be no recognizable facial gestalt. A significant subset of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals show facial asymmetry (5/10) as well as micrognathia (5/10). Other features include a high forehead (3/10) and synophrys (3/10).</p><p><b>Neonatal or infantile feeding difficulties</b> including poor suck, impaired bottle feeding, and failure to thrive are common and are often the presenting findings, similar to what can be observed in other causes of developmental delay and/or ID. Gastrostomy tube feeding has been required in at least one child.</p><p><b>Spine abnormalities</b> (5/10) are mainly mild scoliosis (3/10) and kyphosis (2/10).</p><p>The following features have been observed in fewer individuals:</p><ul><li class="half_rhythm"><div>Syndactyly of the second and third toes (3/10)</div></li><li class="half_rhythm"><div>Recurrent infections (3/10)</div></li><li class="half_rhythm"><div>Constipation (2/10)</div></li><li class="half_rhythm"><div>Urinary incontinence (2/10)</div></li></ul><p>Other anomalies, each reported in one individual, include:</p><ul><li class="half_rhythm"><div>Congenital ptosis</div></li><li class="half_rhythm"><div>Amblyopia and strabismus</div></li><li class="half_rhythm"><div>Hypercalcemia</div></li><li class="half_rhythm"><div>Epilepsy</div></li><li class="half_rhythm"><div>Tremor</div></li><li class="half_rhythm"><div>Wide-based ataxic gait</div></li><li class="half_rhythm"><div>Pectus excavatum</div></li></ul><p><b>Individuals with a <i>de</i>
<i>novo</i> presumably pathogenic <i>TRIO</i> variant ascertained from large ID/ASD cohorts.</b> A few of these 11 less well-characterized individuals may have a more severe or complex <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> as a result of other concomitant genetic findings including single-nucleotide variants or copy-number variants elsewhere in their genome [<a class="bk_pop" href="#trio-id.REF.de_ligt.2012.1921">de Ligt et al 2012</a>, <a class="bk_pop" href="#trio-id.REF.allen.2013.217">Allen et al 2013</a>, <a class="bk_pop" href="#trio-id.REF.pengelly.2016.735">Pengelly et al 2016</a>].</p></div><div id="trio-id.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>To date the number of published cases (i.e., 10) with detailed genotypic and phenotypic information is insufficient to identify a <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlation based on the type of <i>TRIO</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> or the <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of the protein <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</p></div><div id="trio-id.Penetrance"><h3>Penetrance</h3><p>Information available is insufficient to allow conclusions regarding the <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> of <i>TRIO</i> pathogenic variants. Based on the family reported by <a class="bk_pop" href="#trio-id.REF.pengelly.2016.735">Pengelly et al [2016]</a>, some degree of intrafamilial clinical variability can be seen. Variable expressivity may lead to underascertainment of mildly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and possibly explain the presence (on rare occasions) of individuals harboring presumably pathogenic variants in <i>TRIO</i> in control population-based cohorts such as the Exome Aggregation Consortium (ExAC) [<a class="bk_pop" href="#trio-id.REF.lek.2016.285">Lek et al 2016</a>].</p></div><div id="trio-id.Prevalence"><h3>Prevalence</h3><p>In the following three studies, <i>TRIO</i>-related ID accounted for seven individuals with ID and/or ASD:</p><ul><li class="half_rhythm"><div>Three of more than 2,300 individuals with ID had a pathogenic <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> <i>TRIO</i> variant identified by targeted sequencing [<a class="bk_pop" href="#trio-id.REF.ba.2016.892">Ba et al 2016</a>].</div></li><li class="half_rhythm"><div>Three of 1,133 children with severe, undiagnosed developmental disorders had a <i>de novo TRIO</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#trio-id.REF.fitzgerald.2015.223">Fitzgerald et al 2015</a>].</div></li><li class="half_rhythm"><div>One of 209 children with ASD who were <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single occurrence in the family) and in whom initial investigation had excluded the presence of large <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> copy number variants had a <i>de novo</i>
<i>TRIO</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#trio-id.REF.oroak.2012.246">O'Roak et al 2012</a>].</div></li></ul><p>The prevalence of <i>TRIO</i>-related ID may, however, be difficult to establish given the underascertainment of less severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, the ascertainment bias for individuals <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> or <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> variant, and the genetic testing used to exclude individuals with a known diagnosis from the ID/ASD cohorts studied for <i>TRIO</i> variants.</p></div></div><div id="trio-id.Genetically_Related_Allelic_Diso"><h2 id="_trio-id_Genetically_Related_Allelic_Diso_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants in <i>TRIO</i>.</p></div><div id="trio-id.Differential_Diagnosis"><h2 id="_trio-id_Differential_Diagnosis_">Differential Diagnosis</h2><p>Developmental delay, intellectual disability (ID), and/or autism spectrum disorder (ASD) and microcephaly are among the major features in <i>TRIO</i>-related ID for which <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals may be referred for genetic evaluation. Phenotypic features associated with <i>TRIO</i> pathogenic variants are not sufficient to diagnose <i>TRIO</i>-related ID.</p><p>All genes known to be associated with nonsyndromic intellectual disability (~150 genes have been identified, see OMIM Phenotypic Series: <a href="https://omim.org/phenotypicSeries/PS156200" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Intellectual disability, autosomal dominant</a>; <a href="https://omim.org/phenotypicSeries/PS249500" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Intellectual disability, autosomal recessive</a>; and <a href="https://omim.org/phenotypicSeries/PS309530" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Intellectual disability, nonsyndromic, X-linked</a>) should be included in the differential diagnosis of <i>TRIO</i>-related ID.</p><p>Diagnoses that could, however, be considered in individuals with findings suggestive of <i>TRIO</i>-related ID:</p><ul><li class="half_rhythm"><div><a href="/books/n/gene/angelman/"><b>Angelman syndrome</b></a>
<b>(AS),</b> caused by disruption of maternally <a class="def" href="/books/n/gene/glossary/def-item/imprinted/">imprinted</a> <i>UBE3A</i>. Developmental delay and microcephaly are common in AS. One individual with <i>TRIO</i>-related ID had significant motor and language delays and was nonverbal at age nine years; in addition, he had gait anomalies, nocturnal seizures, and facial features reminiscent of AS [<a class="bk_pop" href="#trio-id.REF.pengelly.2016.735">Pengelly et al 2016</a>]. However, in <i>TRIO</i>-related ID the degree of developmental delay and ID is usually milder than in AS and seizures are not common, having been reported in only two individuals to date [<a class="bk_pop" href="#trio-id.REF.allen.2013.217">Allen et al 2013</a>, <a class="bk_pop" href="#trio-id.REF.pengelly.2016.735">Pengelly et al 2016</a>].</div></li><li class="half_rhythm"><div><a href="/books/n/gene/rett/"><b><i>MECP2</i>-related disorders</b></a><b>,</b> inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner. Overlapping features between <i>TRIO</i>-related ID and <i>MECP2</i>-related disorders include developmental delay, microcephaly, and behavioral abnormalities including autistic traits and/or stereotypic behavior and feeding difficulties. The degree of delay is, however, usually less severe in <i>TRIO</i>-related ID, and developmental regression, which is observed in classic Rett syndrome, has not been described to date.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/pitt-hopkins/"><b>Pitt-Hopkins syndrome</b></a>
<b>(PTHS),</b> caused by <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> of <i>TCF4</i>. Overlapping features include developmental delay and microcephaly. Seizures (although rare in <i>TRIO</i>-related ID) may be part of both disorders. One reported individual with severe ID harbored presumably pathogenic <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> variants in both <i>TCF4</i> and <i>TRIO</i>, and although his <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> was considered more compatible with PTHS, the authors debated the phenotypic contribution of the <i>TRIO</i> variants [<a class="bk_pop" href="#trio-id.REF.de_ligt.2012.1921">de Ligt et al 2012</a>]. Episodic hyperventilation has not been described to date in individuals with <i>TRIO</i>-related ID.</div></li></ul></div><div id="trio-id.Management"><h2 id="_trio-id_Management_">Management</h2><div id="trio-id.Evaluations_and_Referrals_Follow"><h3>Evaluations and Referrals Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with <i>TRIO</i>-related intellectual disability (ID), the evaluations and referrals summarized in <a class="figpopup" href="/books/NBK447257/table/trio-id.T.recommended_evaluations_follow/?report=objectonly" target="object" rid-figpopup="figtrioidTrecommendedevaluationsfollow" rid-ob="figobtrioidTrecommendedevaluationsfollow">Table 2</a> are recommended.</p><p>Note: Some evaluations are age dependent and may not be relevant at the time of initial diagnosis (e.g., recommendation for traits suggestive of an autism spectrum disorder in an infant).</p><div id="trio-id.T.recommended_evaluations_follow" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Recommended Evaluations Following Initial Diagnosis of <i>TRIO</i>-Related Intellectual Disability</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK447257/table/trio-id.T.recommended_evaluations_follow/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__trio-id.T.recommended_evaluations_follow_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_trio-id.T.recommended_evaluations_follow_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/Concern</th><th id="hd_h_trio-id.T.recommended_evaluations_follow_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_trio-id.T.recommended_evaluations_follow_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment</th></tr></thead><tbody><tr><td headers="hd_h_trio-id.T.recommended_evaluations_follow_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Growth</b></td><td headers="hd_h_trio-id.T.recommended_evaluations_follow_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assessment of growth parameters to identify those w/failure to thrive</td><td headers="hd_h_trio-id.T.recommended_evaluations_follow_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_trio-id.T.recommended_evaluations_follow_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>ENT / Mouth</b></td><td headers="hd_h_trio-id.T.recommended_evaluations_follow_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation for dental crowding &#x00026;/or failed/delayed tooth eruption</td><td headers="hd_h_trio-id.T.recommended_evaluations_follow_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider referral to dentist or orthodontist.</td></tr><tr><td headers="hd_h_trio-id.T.recommended_evaluations_follow_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Gastroenterology/</b><br /><b>Feeding</b></td><td headers="hd_h_trio-id.T.recommended_evaluations_follow_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assessment for feeding problems, incl difficulty w/sucking/swallowing, GERD, constipation</td><td headers="hd_h_trio-id.T.recommended_evaluations_follow_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Refer to feeding therapist if feeding problems are identified.</td></tr><tr><td headers="hd_h_trio-id.T.recommended_evaluations_follow_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Musculoskeletal</b></td><td headers="hd_h_trio-id.T.recommended_evaluations_follow_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Clinical evaluation for scoliosis &#x00026;/or kyphosis</td><td headers="hd_h_trio-id.T.recommended_evaluations_follow_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Radiographic scoliosis survey (x-rays of spine) based on clinical suspicion; consider referral to orthopedic surgeon if scoliosis is present.</td></tr><tr><td headers="hd_h_trio-id.T.recommended_evaluations_follow_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Psychiatric/</b><br /><b>Behavioral</b></td><td headers="hd_h_trio-id.T.recommended_evaluations_follow_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In individuals age &#x0003e;12 mos: clinical screening for attention/ concentration problems, aggression, &#x00026;/or traits suggestive of an ASD</td><td headers="hd_h_trio-id.T.recommended_evaluations_follow_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider referral for formal testing, incl Autism Diagnostic Interview &#x00026; Autism Diagnostic Observation Schedule.</td></tr><tr><td headers="hd_h_trio-id.T.recommended_evaluations_follow_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Other</b></td><td headers="hd_h_trio-id.T.recommended_evaluations_follow_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Multidisciplinary developmental evaluation incl motor, speech/language evaluation, general cognitive &#x00026; vocational skills</td><td headers="hd_h_trio-id.T.recommended_evaluations_follow_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Refer to developmental pediatrician and/or developmental psychologist.</td></tr><tr><td headers="hd_h_trio-id.T.recommended_evaluations_follow_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Review of medical history for recurrent infections</td><td headers="hd_h_trio-id.T.recommended_evaluations_follow_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">If present, consider referral to immunologist.</td></tr><tr><td headers="hd_h_trio-id.T.recommended_evaluations_follow_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Consultation w/clinical geneticist &#x00026;/or genetic counselor</td><td headers="hd_h_trio-id.T.recommended_evaluations_follow_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">ASD = autism spectrum disorder; GERD = gastroesophageal reflux disease</p></div></dd></dl></div></div></div></div><div id="trio-id.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>See <a class="figpopup" href="/books/NBK447257/table/trio-id.T.treatment_of_manifestations_in/?report=objectonly" target="object" rid-figpopup="figtrioidTtreatmentofmanifestationsin" rid-ob="figobtrioidTtreatmentofmanifestationsin">Table 3</a>.</p><div id="trio-id.T.treatment_of_manifestations_in" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Treatment of Manifestations in Individuals with <i>TRIO</i>-Related Intellectual Disability</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK447257/table/trio-id.T.treatment_of_manifestations_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__trio-id.T.treatment_of_manifestations_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_trio-id.T.treatment_of_manifestations_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Manifestation/Concern</th><th id="hd_h_trio-id.T.treatment_of_manifestations_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Treatment</th><th id="hd_h_trio-id.T.treatment_of_manifestations_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Considerations/Other</th></tr></thead><tbody><tr><td headers="hd_h_trio-id.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Dental crowding /</b><br /><b>Malocclusion</b></td><td headers="hd_h_trio-id.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment as recommended by dentist/orthodontist</td><td headers="hd_h_trio-id.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_trio-id.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Poor weight gain / Failure to thrive</b></td><td headers="hd_h_trio-id.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Feeding therapy; gastrostomy tube placement may be required for persistent feeding issues.</td><td headers="hd_h_trio-id.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dietary diary &#x00026; calorie counts may be requested.</td></tr><tr><td headers="hd_h_trio-id.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>GERD and/or constipation</b></td><td headers="hd_h_trio-id.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment(s)</td><td headers="hd_h_trio-id.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_trio-id.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Seizures</b></td><td headers="hd_h_trio-id.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment(s) as recommended by neurologist</td><td headers="hd_h_trio-id.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_trio-id.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Scoliosis/Kyphosis</b></td><td headers="hd_h_trio-id.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment as recommended by orthopedist</td><td headers="hd_h_trio-id.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">GERD = gastroesophageal reflux disease</p></div></dd></dl></div></div></div><div id="trio-id.Developmental_Delay__Intellectua"><h4>Developmental Delay / Intellectual Disability Management Issues</h4><p>The following information represents typical management recommendations for individuals with developmental delay / intellectual disability in the United States; standard recommendations may vary from country to country.</p><p><b>Ages 0-3 years.</b> Referral to an early intervention program is recommended for access to occupational, physical, speech, and feeding therapy. In the US, early intervention is a nationwide federally funded program available in all states.</p><p><b>Ages 3-5 years.</b> In the US, developmental preschool through the local public school district may be considered. An evaluation will occur before placement to determine needed services and therapies and will be subsequently written into an individualized education plan (IEP).</p><p><b>Ages 5-21 years</b></p><ul><li class="half_rhythm"><div>In the US, an IEP based on the individual's level of function can be developed by the local public school district. Severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children are permitted to remain in the public school district until age 21.</div></li><li class="half_rhythm"><div>Discussion about transition plans including financial, vocation/employment, and medical arrangements should begin at age 12 years. Developmental pediatricians can provide assistance with transition to adulthood.</div></li></ul><p><b>All ages.</b> Consultation with a developmental pediatrician is recommended to ensure that appropriate community, state, and educational agencies are involved and to support parents.</p><p>Consideration of private supportive therapies based on the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual's needs is recommended. Specific recommendations regarding type of therapy can be made by a developmental pediatrician.</p><p>In the US:</p><ul><li class="half_rhythm"><div>Developmental Disabilities Administration (DDA) enrollment is recommended. DDA is a public agency that provides services and support to qualified individuals. Eligibility differs by state but is typically determined by diagnosis and/or associated cognitive/adaptive disabilities.</div></li><li class="half_rhythm"><div>Families with limited income and resources may also qualify for supplemental security income (SSI) for their child with a disability.</div></li></ul></div><div id="trio-id.Motor_Dysfunction"><h4>Motor Dysfunction</h4><p><b>Gross motor dysfunction</b></p><ul><li class="half_rhythm"><div>Physical therapy is recommended to maximize mobility.</div></li><li class="half_rhythm"><div>Consider use of durable medical equipment as needed (e.g., orthotics, adaptive strollers).</div></li></ul><p><b>Fine motor dysfunction.</b> Occupational therapy is recommended for difficulty with fine motor skills that affect adaptive function such as feeding, grooming, dressing, and writing.</p><p><b>Oral motor dysfunction.</b> Feeding therapy, typically from an occupational or speech therapist, is recommended for <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals who have difficulty feeding due to poor oral motor control, assuming the individual is safe to eat by mouth.</p><p><b>Communication issues.</b> Consider evaluation for alternative means of communication (e.g., <a href="http://www.asha.org/NJC/AAC/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Augmentative and Alternative Communication</a>) for individuals who have expressive language difficulties.</p></div><div id="trio-id.SocialBehavioral_Concerns"><h4>Social/Behavioral Concerns</h4><p>Children may qualify for and benefit from interventions used in treatment of autism spectrum disorder, including applied behavior analysis (ABA). ABA therapy is targeted to the individual child's behavioral, social, and adaptive strengths and weaknesses and is typically performed one on one with a board-certified behavior analyst. Effectiveness should be evaluated on an individual basis.</p><p>Consultation with a developmental pediatrician may be helpful in guiding parents through appropriate behavior management strategies or providing prescription medications (e.g., to treat attention-deficit/hyperactivity disorder) when necessary.</p><p>Concerns about serious aggressive or destructive behavior can be addressed by a pediatric psychiatrist.</p></div></div><div id="trio-id.Surveillance"><h3>Surveillance</h3><p>The following are appropriate:</p><ul><li class="half_rhythm"><div>Regular dietary evaluation in infancy to ensure optimal nutritional status</div></li><li class="half_rhythm"><div>Monitoring of developmental progress and educational needs</div></li><li class="half_rhythm"><div>Behavioral assessment for attention, aggression, and/or social communication difficulties</div></li><li class="half_rhythm"><div>Monitoring for spine deformities beginning in early childhood</div></li><li class="half_rhythm"><div>Regular evaluation of teeth; frequency determined by a dentist based on dental condition</div></li></ul></div><div id="trio-id.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#trio-id.Related_Genetic_Counseling_Issue">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="trio-id.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="trio-id.Genetic_Counseling"><h2 id="_trio-id_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="trio-id.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>TRIO</i>-related intellectual disability (ID) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="trio-id.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The majority of individuals diagnosed with <i>TRIO</i>-related ID have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. The proportion of cases caused by a <i>de novo</i> pathogenic variant is, however, unknown.</div></li><li class="half_rhythm"><div>Some individuals diagnosed with <i>TRIO</i>-related ID have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent. Because <i>TRIO</i>-related ID is likely underdiagnosed, the actual proportion of <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (defined as individuals with no obvious family history) and <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> cases (defined as the presence of &#x02265;2 related affected individuals) cannot be determined.</div></li><li class="half_rhythm"><div>Cumulative data on individuals published to date show that the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> was inherited from a similarly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent in roughly 40% of individuals reported in smaller studies [<a class="bk_pop" href="#trio-id.REF.ba.2016.892">Ba et al 2016</a>, <a class="bk_pop" href="#trio-id.REF.pengelly.2016.735">Pengelly et al 2016</a>]; inclusion of additional individuals from larger ID/ASD cohorts with suspected diagnosis of <i>TRIO</i>-related ID suggests that this proportion may be as low as 20% (although 20% may reflect an ascertainment bias for individuals with a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the larger studies).</div></li><li class="half_rhythm"><div>Following identification of a <i>TRIO</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>, detailed evaluation of the parental medical history, comprehensive clinical examination, and <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> should be offered to both parents to determine if one has a previously unidentified <i>TRIO</i> variant.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, possible explanations include a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent (though theoretically possible, no instances of germline mosaicism have been reported to date).</div></li><li class="half_rhythm"><div>The family history of some individuals diagnosed with <i>TRIO</i>-related intellectual disability may appear to be negative as a result of failure to recognize the disorder in family members. Therefore, an apparently negative family history cannot be confirmed unless <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> has been performed on the parents of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to sibs of a proband depends on the genetic status of the proband's parents:</p><ul><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has the <i>TRIO</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to the sibs of inheriting the variant is 50%; intrafamilial clinical variability has been observed [<a class="bk_pop" href="#trio-id.REF.pengelly.2016.735">Pengelly et al 2016</a>].</div></li><li class="half_rhythm"><div>If the <i>TRIO</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the empiric <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> to sibs is approximately 1% because of the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> [<a class="bk_pop" href="#trio-id.REF.rahbari.2016.126">Rahbari et al 2016</a>].</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with <i>TRIO</i>-related ID has a 50% chance of inheriting the <i>TRIO</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>; intrafamilial clinical variability has been observed [<a class="bk_pop" href="#trio-id.REF.pengelly.2016.735">Pengelly et al 2016</a>].</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent has the <i>TRIO</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members may be at risk.</p></div><div id="trio-id.Related_Genetic_Counseling_Issue"><h3>Related Genetic Counseling Issues</h3><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant identified in the proband or clinical evidence of the disorder, the pathogenic variant is likely <i>de novo</i>. However, non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="trio-id.Prenatal_Testing_and_Preimplanta"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>TRIO</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="trio-id.Resources"><h2 id="_trio-id_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>American Association on Intellectual and Developmental Disabilities (AAIDD)</b></div><div>501 3rd Street Northwest</div><div>Suite 200</div><div>Washington DC 20001</div><div><b>Phone:</b> 202-387-1968</div><div><b>Fax:</b> 202-387-2193</div><div><b>Email:</b> sis@aaidd.org</div><div><a href="http://www.aaidd.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.aaidd.org</a></div></li><li class="half_rhythm"><div><b>Medline Plus</b></div><div><a href="http://www.nlm.nih.gov/medlineplus/ency/article/001523.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Intellectual Disability</a></div></li><li class="half_rhythm"><div><b>National Center on Birth Defects and Developmental Disabilities</b></div><div>1600 Clifton Road</div><div>MS E-87</div><div>Atlanta GA 30333</div><div><b>Phone:</b> 800-232-4636 (toll-free); 888-232-6348 (TTY)</div><div><b>Email:</b> cdcinfo@cdc.gov</div><div><a href="http://www.cdc.gov/ncbddd/dd/ddmr.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Intellectual Disability</a></div></li><li class="half_rhythm"><div><b>VOR: Speaking out for people with intellectual and developmental disabilities</b></div><div>836 South Arlington Heights Road, #351</div><div>Elk Grove Village IL 60007</div><div><b>Phone:</b> 877-399-4867</div><div><b>Fax:</b> 847-253-0675</div><div><b>Email:</b> info@vor.net</div><div><a href="http://www.vor.net/index.php" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.vor.net</a></div></li></ul></div><div id="trio-id.Molecular_Genetics"><h2 id="_trio-id_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="trio-id.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>TRIO-Related Intellectual Disability: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK447257/table/trio-id.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__trio-id.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_trio-id.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_trio-id.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_trio-id.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_trio-id.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_trio-id.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_trio-id.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/7204" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>TRIO</i></a></td><td headers="hd_b_trio-id.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=7204" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">5p15<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_trio-id.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O75962" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Triple functional domain protein</a></td><td headers="hd_b_trio-id.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=TRIO" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TRIO</a></td><td headers="hd_b_trio-id.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=TRIO[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TRIO</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="trio-id.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="trio-id.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for TRIO-Related Intellectual Disability (<a href="/omim/601893,617061" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK447257/table/trio-id.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__trio-id.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/601893" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">601893</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">TRIPLE FUNCTIONAL DOMAIN; TRIO</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/617061" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">617061</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>TRIO</i> spans about 366.5 kb and consists of 57 exons encoding 3,097 amino acids (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007118.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_007118.3</a>). For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK447257/#trio-id.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Benign variants.</b> Loss-of-function variants have been observed in large-scale reference population datasets (e.g., the Exome Aggregation Consortium [ExAC] dataset) [<a class="bk_pop" href="#trio-id.REF.lek.2016.285">Lek et al 2016</a>]. Among these, few of the truncating variants are located in the last <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a>, presumably escaping <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>-mediated decay (NMD). Although these databases have made attempts to exclude individuals with severe pediatric diseases, this may not be the case for less severe phenotypes [<a class="bk_pop" href="#trio-id.REF.lek.2016.285">Lek et al 2016</a>].</p><p><b>Pathogenic variants.</b>
<i>TRIO</i> pathogenic variants reported include:</p><ul><li class="half_rhythm"><div>Seven <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, and frameshift variants [<a class="bk_pop" href="#trio-id.REF.ba.2016.892">Ba et al 2016</a>, <a class="bk_pop" href="#trio-id.REF.pengelly.2016.735">Pengelly et al 2016</a>];</div></li><li class="half_rhythm"><div>One intragenic <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> [<a class="bk_pop" href="#trio-id.REF.ba.2016.892">Ba et al 2016</a>].</div></li></ul><p>Given the small number of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals described to date, <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> variants require detailed clinical assessment to determine if clinical features of <i>TRIO-</i>related ID are present.</p><div id="trio-id.T.trio_pathogenic_variants_discu" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p><i>TRIO</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK447257/table/trio-id.T.trio_pathogenic_variants_discu/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__trio-id.T.trio_pathogenic_variants_discu_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_trio-id.T.trio_pathogenic_variants_discu_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_trio-id.T.trio_pathogenic_variants_discu_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_trio-id.T.trio_pathogenic_variants_discu_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_trio-id.T.trio_pathogenic_variants_discu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.649A&#x0003e;T</td><td headers="hd_h_trio-id.T.trio_pathogenic_variants_discu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg217Ter</td><td headers="hd_h_trio-id.T.trio_pathogenic_variants_discu_1_1_1_3" rowspan="7" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007118.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_007118<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/45439359" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_009049<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_trio-id.T.trio_pathogenic_variants_discu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.3752delA</td><td headers="hd_h_trio-id.T.trio_pathogenic_variants_discu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asp1251ValfsTer11</td></tr><tr><td headers="hd_h_trio-id.T.trio_pathogenic_variants_discu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.4128G&#x0003e;A</td><td headers="hd_h_trio-id.T.trio_pathogenic_variants_discu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Trp1376Ter</td></tr><tr><td headers="hd_h_trio-id.T.trio_pathogenic_variants_discu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.4283G&#x0003e;A</td><td headers="hd_h_trio-id.T.trio_pathogenic_variants_discu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg1428Gln</td></tr><tr><td headers="hd_h_trio-id.T.trio_pathogenic_variants_discu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.4381C&#x0003e;A</td><td headers="hd_h_trio-id.T.trio_pathogenic_variants_discu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro1461Thr</td></tr><tr><td headers="hd_h_trio-id.T.trio_pathogenic_variants_discu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.3239A&#x0003e;T&#x000a0;<sup>1</sup></td><td headers="hd_h_trio-id.T.trio_pathogenic_variants_discu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asn1080Ile&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_trio-id.T.trio_pathogenic_variants_discu_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.4466delA</td><td headers="hd_h_trio-id.T.trio_pathogenic_variants_discu_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln1489ArgfsTer12</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin"><a class="bk_pop" href="#trio-id.REF.ba.2016.892">Ba et al [2016]</a>, <a class="bk_pop" href="#trio-id.REF.pengelly.2016.735">Pengelly et al [2016]</a></p></div></dd><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="trio-id.TF.4.1"><p class="no_margin">No other <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants lying within the spectrin repeat <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> have been reported to date among the well-characterized individuals with <i>TRIO</i>-related ID; thus, the clinical consequences of this variant have not been determined.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>TRIO</i> encodes the triple functional <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> protein consisting of several domains, notably an N-terminal SEC14 domain, several spectrin repeats, two Dbl-homology-Pleckstrin-homology (DH-PH) Rho-guanine exchange factor (GEF) domains, and a C-terminal serine/threonine kinase domain. The first DH-PH domain activates Rac1 and RhoG, while the second acts on RhoA. The protein product of <i>TRIO</i>, through its two GEF domains, acts as a Rho GTPase regulator.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Aberrant Rho signaling at the synapse and pathogenic variants in genes encoding the Rho GTPase regulators and effectors have been implicated in human neurologic diseases and intellectual disability [<a class="bk_pop" href="#trio-id.REF.govek.2005.1">Govek et al 2005</a>, <a class="bk_pop" href="#trio-id.REF.ba.2013.2368">Ba et al 2013</a>]. <i>TRIO</i> is highly expressed at early stages of mammalian development and its expression decreases rapidly during postnatal development, thus suggesting a role in early neuronal development. It has been proposed that TRIO serves as an endogenous break for synaptic development and loss of its activity may induce premature maturation of the excitatory synapses, similar to what has been described in ASD models, through redistribution of postsynaptic AMPA receptors. For a summary refer to <a class="bk_pop" href="#trio-id.REF.ba.2016.892">Ba et al [2016]</a>.</p><p>All but one <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> or <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> variant associated with disease appeared to affect Trio-mediated Rac1 activation at the functional level [<a class="bk_pop" href="#trio-id.REF.pengelly.2016.735">Pengelly et al 2016</a>]. Of note, these variants lie within the first DH-PH GEF <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of the protein. A single variant, however, was predicted to alter a residue within a spectrin repeat (<a class="figpopup" href="/books/NBK447257/table/trio-id.T.trio_pathogenic_variants_discu/?report=objectonly" target="object" rid-figpopup="figtrioidTtriopathogenicvariantsdiscu" rid-ob="figobtrioidTtriopathogenicvariantsdiscu">p.Asn1080Ile</a>) and was found not to affect Rac1 activation. Based on this finding and the atypical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of the respective individual, the authors speculated that some features of <i>TRIO</i>-related ID, such as microcephaly or mild speech delay, may be secondary (and specific) to diminished Rac1 activation.</p></div><div id="trio-id.References"><h2 id="_trio-id_References_">References</h2><div id="trio-id.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="trio-id.REF.allen.2013.217">Allen AS, Berkovic SF, Cossette P, Delanty N, Dlugos D, Eichler EE, Epstein MP, Glauser T, Goldstein DB, Han Y, Heinzen EL, Hitomi Y, Howell KB, Johnson MR, Kuzniecky R, Lowenstein DH, Lu YF, Madou MR, Marson AG, Mefford HC, Esmaeeli Nieh S, O'Brien TJ, Ottman R, Petrovski S, Poduri A, Ruzzo EK, Scheffer IE, Sherr EH, Yuskaitis CJ, Abou-Khalil B, Alldredge BK, Bautista JF, Berkovic SF, Boro A, Cascino GD, Consalvo D, Crumrine P, Devinsky O, Dlugos D, Epstein MP, Fiol M, Fountain NB, French J, Friedman D, Geller EB, Glauser T, Glynn S, Haut SR, Hayward J, Helmers SL, Joshi S, Kanner A, Kirsch HE, Knowlton RC, Kossoff EH, Kuperman R, Kuzniecky R, Lowenstein DH, McGuire SM, Motika PV, Novotny EJ, Ottman R, Paolicchi JM, Parent JM, Park K, Poduri A, Scheffer IE, Shellhaas RA, Sherr EH, Shih JJ, Singh R, Sirven J, Smith MC, Sullivan J, Lin Thio L, Venkat A, Vining EP, Von Allmen GK, Weisenberg JL, Widdess-Walsh P, Winawer MR, et al.  Epi4K Consortium Study: de novo mutations in epileptic encephalopathies. <span><span class="ref-journal">Nature. </span>2013;<span class="ref-vol">501</span>:217–21.</span> [<a href="/pmc/articles/PMC3773011/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3773011</span></a>] [<a href="/pubmed/23934111" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23934111</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trio-id.REF.ba.2013.2368">Ba W, van der Raadt J, Nadif Kasri N. Rho GTPase signaling at the synapse: implications for intellectual disability. <span><span class="ref-journal">Exp Cell Res. </span>2013;<span class="ref-vol">319</span>:2368–74.</span> [<a href="/pubmed/23769912" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23769912</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trio-id.REF.ba.2016.892">Ba W, Yan Y, Reijnders MR, Schuurs-Hoeijmakers JH, Feenstra I, Bongers EM, Bosch DG, De Leeuw N, Pfundt R, Gilissen C, De Vries PF, Veltman JA, Hoischen A, Mefford HC, Eichler EE, Vissers LE, Nadif Kasri N, De Vries BB. TRIO loss of function is associated with mild intellectual disability and affects dendritic branching and synapse function. <span><span class="ref-journal">Hum Mol Genet. </span>2016;<span class="ref-vol">25</span>:892–902.</span> [<a href="/pmc/articles/PMC4754042/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4754042</span></a>] [<a href="/pubmed/26721934" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26721934</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trio-id.REF.de_ligt.2012.1921">de Ligt J, Willemsen MH, van Bon BW, Kleefstra T, Yntema HG, Kroes T, Vulto-van Silfhout AT, Koolen DA, de Vries P, Gilissen C, del Rosario M, Hoischen A, Scheffer H, de Vries BB, Brunner HG, Veltman JA, Vissers LE. Diagnostic exome sequencing in persons with severe intellectual disability. <span><span class="ref-journal">N Engl J Med. </span>2012;<span class="ref-vol">367</span>:1921–9.</span> [<a href="/pubmed/23033978" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23033978</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trio-id.REF.de_rubeis.2014.209">De Rubeis S, He X, Goldberg AP, Poultney CS, Samocha K, Cicek AE, Kou Y, Liu L, Fromer M, Walker S, Singh T, Klei L, Kosmicki J, Shih-Chen F, Aleksic B, Biscaldi M, Bolton PF, Brownfeld JM, Cai J, Campbell NG, Carracedo A, Chahrour MH, Chiocchetti AG, Coon H, Crawford EL, Curran SR, Dawson G, Duketis E, Fernandez BA, Gallagher L, Geller E, Guter SJ, Hill RS, Ionita-Laza J, Jimenz Gonzalez P, Kilpinen H, Klauck SM, Kolevzon A, Lee I, Lei I, Lei J, Lehtim&#x000e4;ki T, Lin CF, Ma'ayan A, Marshall CR, McInnes AL, Neale B, Owen MJ, Ozaki N, Parellada M, Parr JR, Purcell S, Puura K, Rajagopalan D, Rehnstr&#x000f6;m K, Reichenberg A, Sabo A, Sachse M, Sanders SJ, Schafer C, Schulte-R&#x000fc;ther M, Skuse D, Stevens C, Szatmari P, Tammimies K, Valladares O, Voran A, Li-San W, Weiss LA, Willsey AJ, Yu TW, Yuen RK, Cook EH, Freitag CM, Gill M, Hultman CM, Lehner T, Palotie A, Schellenberg GD, Sklar P, State MW, Sutcliffe JS, Walsh CA, Scherer SW, Zwick ME, Barett JC, Cutler DJ, Roeder K, Devlin B, Daly MJ, Buxbaum JD, et al.  Synaptic, transcriptional and chromatin genes disrupted in autism. <span><span class="ref-journal">Nature. </span>2014;<span class="ref-vol">515</span>:209–15.</span> [<a href="/pmc/articles/PMC4402723/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4402723</span></a>] [<a href="/pubmed/25363760" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25363760</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trio-id.REF.fitzgerald.2015.223">Fitzgerald TW, Gerety SS, Jones WD, van Kogelenberg M, King DA, McRae J, Morley KI, Parthiban V, Al-Turki S, Ambridge K, Barrett DM, Bayzetinova T, Clayton S, Coomber EL, Gribble S, Jones P, Krishnappa N, Mason LE, Middleton A, Miller R, Prigmore E, Rajan D, Sifrim A, Tivey AR, Ahmed M, Akawi N, Andrews R, Anjum U, Archer H, Armstrong R, Balasubramanian M, Banerjee R, Baralle D, Batstone P, Baty D, Bennett C, Berg J, Bernhard B, Bevan AP, Blair E, Blyth M, Bohanna D, Bourdon L, Bourn D, Brady A, Bragin E, Brewer C, Brueton L, Brunstrom K, Bumpstead SJ, Bunyan DJ, Burn J, Burton J, Canham N, Castle B, Chandler K, Clasper S, Clayton-Smith J, Cole T, Collins A, Collinson MN, Connell F, Cooper N, Cox H, Cresswell L, Cross G, Crow Y, et al.  Deciphering Developmental Disorders Study: Large-scale discovery of novel genetic causes of developmental disorders. <span><span class="ref-journal">Nature. </span>2015;<span class="ref-vol">519</span>:223–8.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="trio-id.REF.govek.2005.1">Govek EE, Newey SE, Van Aelst L. The role of the Rho GTPases in neuronal development. <span><span class="ref-journal">Genes Dev. </span>2005;<span class="ref-vol">19</span>:1–49.</span> [<a href="/pubmed/15630019" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15630019</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trio-id.REF.iossifov.2014.216">Iossifov I, O'Roak BJ, Sanders SJ, Ronemus M, Krumm N, Levy D, Stessman HA, Witherspoon KT, Vives L, Patterson KE, Smith JD, Paeper B, Nickerson DA, Dea J, Dong S, Gonzalez LE, Mandell JD, Mane SM, Murtha MT, Sullivan CA, Walker MF, Waqar Z, Wei L, Willsey AJ, Yamrom B, Lee YH, Grabowska E, Dalkic E, Wang Z, Marks S, Andrews P, Leotta A, Kendall J, Hakker I, Rosenbaum J, Ma B, Rodgers L, Troge J, Narzisi G, Yoon S, Schatz MC, Ye K, McCombie WR, Shendure J, Eichler EE, State MW, Wigler M. The contribution of de novo coding mutations to autism spectrum disorder. <span><span class="ref-journal">Nature. </span>2014;<span class="ref-vol">515</span>:216–21.</span> [<a href="/pmc/articles/PMC4313871/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4313871</span></a>] [<a href="/pubmed/25363768" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25363768</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trio-id.REF.lek.2016.285">Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, O'Donnell-Luria AH, Ware JS, Hill AJ, Cummings BB, Tukiainen T, Birnbaum DP, Kosmicki JA, Duncan LE, Estrada K, Zhao F, Zou J, Pierce-Hoffman E, Berghout J, Cooper DN, Deflaux N, DePristo M, Do R, Flannick J, Fromer M, Gauthier L, Goldstein J, Gupta N, Howrigan D, Kiezun A, Kurki MI, Moonshine AL, Natarajan P, Orozco L, Peloso GM, Poplin R, Rivas MA, Ruano-Rubio V, Rose SA, Ruderfer DM, Shakir K, Stenson PD, Stevens C, Thomas BP, Tiao G, Tusie-Luna MT, Weisburd B, Won HH, Yu D, Altshuler DM, Ardissino D, Boehnke M, Danesh J, Donnelly S, Elosua R, Florez JC, Gabriel SB, Getz G, Glatt SJ, Hultman CM, Kathiresan S, Laakso M, McCarroll S, McCarthy MI, McGovern D, McPherson R, Neale BM, Palotie A, Purcell SM, Saleheen D, Scharf JM, Sklar P, Sullivan PF, Tuomilehto J, Tsuang MT, Watkins HC, Wilson JG, Daly MJ, MacArthur DG, et al.  Analysis of protein-coding genetic variation in 60,706 humans. <span><span class="ref-journal">Nature. </span>2016;<span class="ref-vol">536</span>:285–91.</span> [<a href="/pmc/articles/PMC5018207/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5018207</span></a>] [<a href="/pubmed/27535533" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27535533</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trio-id.REF.oroak.2012.246">O'Roak BJ, Vives L, Girirajan S, Karakoc E, Krumm N, Coe BP, Levy R, Ko A, Lee C, Smith JD, Turner EH, Stanaway IB, Vernot B, Malig M, Baker C, Reilly B, Akey JM, Borenstein E, Rieder MJ, Nickerson DA, Bernier R, Shendure J, Eichler EE. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. <span><span class="ref-journal">Nature. </span>2012;<span class="ref-vol">485</span>:246–50.</span> [<a href="/pmc/articles/PMC3350576/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3350576</span></a>] [<a href="/pubmed/22495309" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22495309</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trio-id.REF.pengelly.2016.735">Pengelly RJ, Greville-Heygate S, Schmidt S, Seaby EG, Jabalameli MR, Mehta SG, Parker MJ, Goudie D, Fagotto-Kaufmann C, Mercer C, Debant A, Ennis S, Baralle D, et al.  Mutations specific to the Rac-GEF domain of TRIO cause intellectual disability and microcephaly. J Med Genet. <span><span class="ref-journal">J Med Genet. </span>2016;<span class="ref-vol">53</span>:735–42.</span> [<a href="/pmc/articles/PMC5264232/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5264232</span></a>] [<a href="/pubmed/27418539" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27418539</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trio-id.REF.rahbari.2016.126">Rahbari R, Wuster A, Lindsay SJ, Hardwick RJ, Alexandrov LB, Al Turki S, Dominiczak A, Morris A, Porteous D, Smith B, Stratton MR, Hurles ME, et al.  Timing, rates and spectra of human germline mutation. <span><span class="ref-journal">Nat Genet. </span>2016;<span class="ref-vol">48</span>:126–33.</span> [<a href="/pmc/articles/PMC4731925/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4731925</span></a>] [<a href="/pubmed/26656846" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26656846</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trio-id.REF.richards.2015.405">Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL, et al.  Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. <span><span class="ref-journal">Genet Med. </span>2015;<span class="ref-vol">17</span>:405–24.</span> [<a href="/pmc/articles/PMC4544753/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4544753</span></a>] [<a href="/pubmed/25741868" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25741868</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="trio-id.REF.sanders.2012.237">Sanders SJ, Murtha MT, Gupta AR, Murdoch JD, Raubeson MJ, Willsey AJ, Ercan-Sencicek AG, DiLullo NM, Parikshak NN, Stein JL, Walker MF, Ober GT, Teran NA, Song Y, El-Fishawy P, Murtha RC, Choi M, Overton JD, Bjornson RD, Carriero NJ, Meyer KA, Bilguvar K, Mane SM, Sestan N, Lifton RP, G&#x000fc;nel M, Roeder K, Geschwind DH, Devlin B, State MW. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. <span><span class="ref-journal">Nature. </span>2012;<span class="ref-vol">485</span>:237–41.</span> [<a href="/pmc/articles/PMC3667984/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3667984</span></a>] [<a href="/pubmed/22495306" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22495306</span></a>]</div></li></ul></div></div><div id="trio-id.Chapter_Notes"><h2 id="_trio-id_Chapter_Notes_">Chapter Notes</h2><div id="trio-id.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>10 August 2017 (bp) Review posted live</div></li><li class="half_rhythm"><div>23 December 2016 (kv) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK447257</span><span class="label">PMID: <a href="/pubmed/28796471" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">28796471</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/aec/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/cmt2c/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK447257&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK447257/?report=reader">PubReader</a></li><li><a href="/books/NBK447257/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK447257" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK447257" style="display:none" title="Cite this Page"><div class="bk_tt">Varvagiannis K, Vissers LELM, Baralle D, et al. TRIO-Related Intellectual Disability. 2017 Aug 10. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK447257/pdf/Bookshelf_NBK447257.pdf">PDF version of this page</a> (449K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#trio-id.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#trio-id.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#trio-id.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#trio-id.Genetically_Related_Allelic_Diso" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#trio-id.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#trio-id.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#trio-id.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#trio-id.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#trio-id.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#trio-id.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#trio-id.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=7204[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">TRIO</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=4433786" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4433786" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4433786" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=4433786" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29190062" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">WAC</i>-Related Intellectual Disability</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">WAC</i>-Related Intellectual Disability<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Varvagiannis K, de Vries BBA, Vissers LELM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30702837" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">CDK13</i>-Related Disorder</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">CDK13</i>-Related Disorder<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bostwick B. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30789692" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">SYNGAP1</i>-Related Intellectual Disability</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">SYNGAP1</i>-Related Intellectual Disability<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Holder JL Jr, Hamdan FF, Michaud JL. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31021590" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">WDR26</i>-Related Intellectual Disability</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">WDR26</i>-Related Intellectual Disability<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Skraban CM, Grand KL, Deardorff MA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31219694" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">GRIN1</i>-Related Neurodevelopmental Disorder</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">GRIN1</i>-Related Neurodevelopmental Disorder<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Platzer K, Lemke JR. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=28796471" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=28796471" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dfc8fcedde089116937f774">TRIO-Related Intellectual Disability - GeneReviews®</a><div class="ralinkpop offscreen_noflow">TRIO-Related Intellectual Disability - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-20T04:09:34-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal102&amp;ncbi_phid=CE8910E7DFC8726100000000045701F7&amp;ncbi_session=CE8910E7DFC8FCD1_1111SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK447257%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK447257&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK447257/&amp;ncbi_pagename=TRIO-Related Intellectual Disability - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8910E7DFC8FCD1_1111SID /projects/books/PBooks@5.22 portal102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>